when were glp 1 drugs invented GLP-1 Looming GLP-1 drug patent expirations
Description
A 2024 study published in JAMA Ophthalmology found an increased risk of NAION for those taking semaglutide medications
Most insurance will only cover semaglutide if its prescribed for an FDA-approved use
Researchers performed a secondary analysis that analyzed published research articles along with existing datasets to study how GLP-1 receptors express themselves in synovial fibroblasts, chondrocytes, and immune cells
These supplements lack the potency and receptor specificity of pharmaceutical interventions
Our clinicians prefer to classify these medications as incretin mimetics, which include drugs that act as GLP-1s, GLP-1/GIPs, and others
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the surmount-4 randomized clinical trial
